Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04294277
Title Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery (PEGASUS)
Acronym PEGASUS
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors European Association of Urology Research Foundation
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
ASST Papa Giovanni XXIII Bergamo Italy Details
Policlinico Sant'Orsola-Malpighi - Azienda Ospedaliero-Univeristaria di Bologna Bologna Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori Milano Italy Details
IRCCS San Raffaele Hospital Milano Italy Details
Fondazione Policlinico Universitario A. Gemelli, IRCCS Roma Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field